HEPATITIS-B-VIRUZIDE

European patent · EP3675637 · In force

Register entry

Publication number
EP3675637
Application number
EP18852434
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 28, 2018
Published
Jul 8, 2020
Granted
Jul 15, 2026
Protection ends at the latest
Aug 27, 2038
Next annual fee due
Aug 31, 2027
IPC classes
C07C 317/44 (2006.01)
C07D 213/00 (2006.01)
A61K 31/33 (2006.01)
A61K 31/34 (2006.01)
A61K 31/35 (2006.01)
A61K 31/39 (2006.01)
A61K 31/40 (2006.01)
A61K 31/41 (2006.01)
A61K 31/42 (2006.01)
A61K 31/44 (2006.01)
A61K 31/47 (2006.01)
A61K 31/51 (2006.01)
A61K 31/70 (2006.01)
A61K 45/06 (2006.01)
A61P 31/20 (2006.01)
Priority
US 201762550992 P 28.08.2017
PCT application
PCT/US2018/048300 28.08.2018
PCT publication
WO2019/046271 07.03.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Aug 3, 2026

    Agent entered

    Representative
    dynamXIP GmbH, Lichtstrasse 35, 4056 Basel

    Published in Swissreg on 03.08.2026

  3. Jul 15, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 15.07.2026

Parties

Inventor

QIU, Yao-ling

Andover, MA 01810, US

CAO, Hui

Belmont, MA 02478, US

GAO, Xuri

Newton, MA 02461, US

KASS, Jordan

Belmont, MA 02478, US

LI, Wei

Lexington, MA 02421, US

PENG, Xiaowen

Sudbury, MA 02420, US

SUH, Byung-chul

Lexington, MA 02420, US

OR, Yat, Sun

Watertown, MA 02472, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.